Centrally administered SGLT2 inhibitor improves gut barrier function through the brain orexin, AMPK, dopamine D2 signaling and the vagal pathway in rats
Centrally administered SGLT2 inhibitor improves gut barrier function through the brain orexin, AMPK, dopamine D2 signaling and the vagal pathway in rats. // Neuroscience Research. – URL: https://www.sciencedirect.com/science/article/pii/S0168010226001227?dgcid=rss_sd_all
Centrally administered SGLT2 inhibitor improves gut barrier function through the brain orexin, AMPK, dopamine D2 signaling and the vagal pathway in rats. Neuroscience Research. https://www.sciencedirect.com/science/article/pii/S0168010226001227?dgcid=rss_sd_all
“Centrally administered SGLT2 inhibitor improves gut barrier function through the brain orexin, AMPK, dopamine D2 signaling and the vagal pathway in rats.” Neuroscience Research.
@article{article9776,
title = {Centrally administered SGLT2 inhibitor improves gut barrier function through the brain orexin, AMPK, dopamine D2 signaling and the vagal pathway in rats},
journal = {Neuroscience Research},
url = {https://www.sciencedirect.com/science/article/pii/S0168010226001227?dgcid=rss_sd_all}
}